DIA Biosimilars 2013

Pharmaron

Pharmaron forms strategic partnership with AstraZeneca

Monday, October 15, 2012 11:47 AM

Pharmaron, an R&D service provider for the pharmaceutical and biotech industries, is partnering with AstraZeneca to support its global innovative medicines units.

More... »

Cenduit: Now with Patient Reminders

Pharmaron to host Merck’s R&D laboratory in China

Wednesday, September 14, 2011 02:13 PM

Pharmaron has reported a strategic partnership with Merck Serono. In the framework of this partnership, Pharmaron's new campus in the Beijing economic and technological development area (BDA) will serve as home to Merck Serono's China R&D laboratory.

More... »

CRF Health – eCOA Forum

Pharmaron raises $40 million in financing round

Tuesday, March 1, 2011 08:42 AM

CRO Pharmaron Holding, of Irvine, Calif. and Beijing, has closed a Series C financing round totaling more than $40 million from existing investors DCM, Legend Capital and others, along with new investor GL Capital Group.

More... »

Pharmaron Beefs Up Preclinical Offerings with Bridge Labs China Acquisition

Thursday, January 14, 2010 06:54 AM

Pharmaron Holdings acquired Bridge Laboratories China this week for an undisclosed sum, building on the contract research organization’s (CRO’s) existing presence in China.  

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs